R&D Systems™ Recombinant Human MOG Protein

Catalog No.	Quantity
85-35M-O050	50 μg

Catalog No. 85-35M-O050 Supplier R&D Systems™ Supplier No. 8535MO050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human MOG Protein is derived from NS0. The Recombinant Human MOG Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q16653
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 4340
• Molecular Weight (g/mol): Observed M.W.: 20-30kDa, reducing conditions, Theoretical M.W.: 16kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human MOG protein Gly30-Gly154,with a substitution at Asp131Ala and a C-terminal 10-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: MGC26137, MOG Ig-AluB, MOGIG2, myelin oligodendrocyte glycoprotein, myelin-oligodendrocyte glycoprotein
• Common Name: MOG
• Gene Symbol: MOG
• Biological Activity: Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons. Recombinant Human MOG, immobilized at 1μg/mL on a 96-well plate, is able to significantly enhance neurite outgrowth.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Mouse myeloma cell line, NS0-derived Gly30-Gly154, with a substitution at Asp131Ala and a C-terminal 10-His tag
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.